AssayIndex
Reports by quarter

Reports submitted in 2025-Q1 · page 15

Anomaly rule set expanded from seven rules to eleven. Median purity for the quarter is 99.14 % area, n=664. Read the 2025-Q1 state-of-the-index report →

672 records17 pagesmedian on this page 98.82 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019941AOD-9604HJHJ-2502-E7144VendorInvestigate2025-Q198.781.93—Buyer-sourced0PASS
AX-2025-019643GHRP-2TFCTFC-2502-D2333Nordanalyt2025-Q199.935.03105.4Supplier-supplied0PASS
AX-2025-019140TesamorelinGSPGSP-2501-G3708PeptideMeter2025-Q198.234.03—Buyer-sourced0PASS
AX-2025-018855DihexaFGPFGP-2408-S8496Janoshik2025-Q199.616.54105.2Buyer-sourced0PASS
AX-2025-018580SemaglutideQYBQYB-2410-V4909Janoshik2025-Q199.523.34—Buyer-sourced0PASS
AX-2025-021043CJC-1295 (no DAC)BCHBCH-2502-A4465Medutest2025-Q197.414.17104.0Buyer-sourced1FAIL
AX-2025-020950BPC-157WXTWXT-2501-J3079PeptideMeter2025-Q198.896.11—Buyer-sourced0PASS
AX-2025-020821ThymalinCPCCPC-2501-V2021Janoshik2025-Q1N/A6.20—Buyer-sourced1N/A
AX-2025-020223SemaglutideGGPepsGGPE-2501-W1875VendorInvestigate2025-Q198.815.24—Buyer-sourced0PASS
AX-2025-019826KPVHomopeptideHOMO-2411-P5026Janoshik2025-Q199.644.71106.5Buyer-sourced0FAIL
AX-2025-018901RetatrutideTFSTFS-{CAT}-9723Janoshik2025-Q198.834.9799.6Buyer-sourced0PASS
AX-2025-020947BPC-157WXTWXT-2501-J3079Nordanalyt2025-Q198.525.36102.0Buyer-sourced0PASS
AX-2025-020923PT-141 (Bremelanotide)WXTWXT-2410-M2421Janoshik2025-Q197.875.47—Buyer-sourced0FAIL
AX-2025-020904MK-677 (Ibutamoren mesylate)WXTWXT-2502-F2050Janoshik2025-Q199.704.69101.0Buyer-sourced0FAIL
AX-2025-020827ThymalinCPCCPC-2501-V2021Janoshik2025-Q1N/A6.64—Buyer-sourced1N/A
AX-2025-020512MOTS-cSSASSA-2501-M6154VendorInvestigate2025-Q197.923.08100.6Buyer-sourced0FAIL
AX-2025-020287BPC-157GGPepsGGPE-2502-S2559Medutest2025-Q198.833.2798.2Buyer-sourced0PASS
AX-2025-019924SelankHJHJ-2501-M6535Janoshik2025-Q199.297.30—Buyer-sourced0PASS
AX-2025-019762SemaglutideHomopeptideHOMO-2501-D4523PeptideMeter2025-Q199.535.67103.4Buyer-sourced0PASS
AX-2025-018746CJC-1295 (no DAC)QSCQSC-2411-D7855Janoshik2025-Q199.423.2989.7Buyer-sourced1MARGINAL
AX-2025-021165SemaglutidePPGPPG-2408-B6709Janoshik2025-Q198.814.61—Laboratory-retained0PASS
AX-2025-021020PT-141 (Bremelanotide)WXTWXT-2411-R3766Janoshik2025-Q198.366.61101.2Buyer-sourced0FAIL
AX-2025-020686SelankSGNSGN-2409-H8807Janoshik2025-Q198.286.0799.8Buyer-sourced0FAIL
AX-2025-020009RetatrutideSWBSWB-2411-R7167Janoshik2025-Q197.734.03—Buyer-sourced0PASS
AX-2025-018432TirzepatideWWBWWB-2411-A2303Medutest2025-Q199.461.7490.2Buyer-sourced1FAIL
AX-2025-021145MOTS-cSIGSIG-2412-6332VendorInvestigate2025-Q198.854.58—Buyer-sourced1MARGINAL
AX-2025-020945BPC-157WXTWXT-2501-J3079Janoshik2025-Q198.645.49105.6Buyer-sourced0PASS
AX-2025-019944AOD-9604HJHJ-2502-E7144PeptideMeter2025-Q198.621.43101.3Buyer-sourced0PASS
AX-2025-019161LL-37SinoPepSNP-2411-X3762PeptideMeter2025-Q199.302.58—Buyer-sourced1MARGINAL
AX-2025-018511SemaglutideWWBWWB-2501-K3141Medutest2025-Q198.984.21—Buyer-sourced1MARGINAL
AX-2025-018476TirzepatideWWBWWB-2502-U2990Janoshik2025-Q198.833.76106.2Laboratory-retained1MARGINAL
AX-2025-020834IpamorelinCPCCPC-2503-J1794Kestrel2025-Q198.486.62—Buyer-sourced0FAIL
AX-2025-020314CJC-1295 (no DAC)GGPepsGGPE-2408-G2525Janoshik2025-Q198.523.10107.4Buyer-sourced0PASS
AX-2025-020189BPC-157ERPERP-2502-P9890Janoshik2025-Q199.794.2794.2Buyer-sourced0PASS
AX-2025-019899TirzepatideHJHJ-2501-P5963PeptideMeter2025-Q198.452.6698.2Buyer-sourced0PASS
AX-2025-019864IGF-1 LR3HJHJ-2410-G5632PeptideMeter2025-Q198.233.43—Buyer-sourced1MARGINAL
AX-2025-019829KPVHomopeptideHOMO-2411-P5026Janoshik2025-Q199.075.03—Buyer-sourced0FAIL
AX-2025-018840PT-141 (Bremelanotide)FGPFGP-2409-W9076Janoshik2025-Q199.835.63—Laboratory-retained0PASS
AX-2025-021026PT-141 (Bremelanotide)WXTWXT-2411-R3766Janoshik2025-Q198.435.65—Buyer-sourced0FAIL
AX-2025-020991CJC-1295 with DACWXTWXT-2409-Y3760Janoshik2025-Q197.215.47102.2Buyer-sourced1FAIL